Programs & Funding

Funding for Therapeutics Development Projects
  • NINDS Cooperative Program in Translational Research (U01). The milestone-driven program supports preclinical optimization and testing of the leads, and projects must be sufficiently advanced that an Investigational New Drug (IND), Investigational Device Exemption (IDE), 510(k), or 510(k) de novo application to the Food and Drug Administration (FDA) can be submitted during the project period.
  • NINDS Exploratory/Developmental Projects in Translational Research (R21). Funding to support any research activities required to advance development of candidate therapeutics (drugs, devices, and biologics). Projects can be supported prior to or in parallel with cooperative agreement funding.

Guidance and Resources for Therapeutics Development Projects
Share to Facebook Share to Twitter Share to Google Plus Share to Linkedin